Phase 3 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with squamous cell cancer of the esophagus (food pipe) that has been confirmed by a tissue sample, and the cancer is at a locally advanced stage but has not spread to distant parts of the body.
- A specialist medical team has agreed that your cancer can be surgically removed.
- You are generally active and able to carry out daily activities with little or no restriction (as measured by a standard health scale).
- Your organs (such as kidneys, liver, and heart) are working well enough to participate.
- If you are a woman who could become pregnant, you must have a negative pregnancy test before joining.
- If you could become pregnant or father a child, you must use a highly effective form of contraception during the study and for at least five months after the last treatment.
- If you are currently breastfeeding, you must stop before receiving the first treatment.
- You are able to attend all required appointments and follow the study schedule without major barriers.
- You are willing and able to give written consent to take part in the trial.
Who may not be able to join:
- Your cancer has already spread to distant parts of the body.
- Your tumor has grown into nearby structures in a way that makes it very difficult to remove (confirm with trial site).
- Your tumor cannot be removed surgically without also removing your voice box (larynx).
- You have serious problems with your kidneys, liver, heart, lungs, or hormonal system that would make combination treatment too risky.
- Your doctors do not think you are likely to tolerate the combination of chemotherapy, radiotherapy, and surgery.
- You have had a previous cancer in the last 5 years, unless it was completely treated or removed at least 5 years ago.
- You have previously had radiotherapy or chemotherapy with radiotherapy in an area that would overlap with the treatment area for this trial.
- You have a known serious allergic reaction to any of the chemotherapy drugs used in this trial.
- You are unable to understand the study information or follow the study instructions due to language barriers, dementia, or a severe mental health condition.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Magnus Nilsson, MD, PhD, Karolinska University Hospital
Phone: +46-707-375186
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival; Global Health-related quality of life (HRQOL); Eating restrictions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.